Maike Nickelsen

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

Norbert Schmitz, Lorenz Trümper, Marita Ziepert et al. · Blood · 2010 · 588 citations · Full text

CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP

Norbert Schmitz, Samira Zeynalova, Maike Nickelsen et al. · Journal of Clinical Oncology · 2016 · 427 citations

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Norbert Schmitz, Maike Nickelsen, Marita Ziepert et al. · The Lancet Oncology · 2012 · 247 citations

Hematological Malignancy, Lymphoid Neoplasia, Conventional Chemotherapy +8

Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial

Viola Poeschel, Gerhard Held, Marita Ziepert et al. · The Lancet · 2019 · 244 citations · Full text

Stage-Adapted Treatment of HIV-Associated Hodgkin Lymphoma: Results of a Prospective Multicenter Study

Marcus Hentrich, Marcel Berger, Christoph Wyen et al. · Journal of Clinical Oncology · 2012 · 119 citations